Surgical matrix patches recalled for labeling correction on wound dehiscence management
CorNeat EverPatch permanent tissue-integrating surgical matrices are the subject of a retroactive labeling correction, following complaints, to include prevention and management of wound dehiscence.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Rubric level 2 covers precautionary recalls; the action is a labeling correction rather than a defect described in the product.
Plain-English summary
The CorNeat EverPatch, REF 1036295, a permanent tissue-integrating surgical matrix measuring 5.0 mm by 6.5 mm by 100 microns, sterile EO and prescription only, UDI-DI G16010362950, is being recalled. Distribution was nationwide in the United States and internationally.
The action is retroactive and was taken, following complaints, as a labeling correction for permanent tissue-integrating surgical matrices to include prevention and management of wound dehiscence. The FDA classified the action as Class II. The notice does not describe a defect in the product itself.
Surgical centres holding this product should follow the manufacturer's instructions for applying the updated labeling.
The recalled product
- Product
- CorNeat EverPatch, REF: 1036295, Permanent Tissue-Integrating Surgical Matrix, 5.0 mm x 6.5 mm x 100 um, SterileEO, RX only
- Manufacturer
- CORNEAT VISION, LTD.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UDI-DI: G16010362950
Distribution
Related recalls
Same manufacturer · CORNEAT VISION, LTD.
See all →- HighScleral reinforcement matrix recalled after complaints of early patch exposure
FDA (Devices) · 2025-10-15
- HighOcular surgical matrix recalled after complaints of early patch exposure
FDA (Devices) · 2025-10-15
Same hazard · labeling correction
See all →- ModerateAbbott Amplatzer Steerable Delivery Sheath instructions for use updated
FDA (Devices) · 2022-04-13
- ModerateHeparin Activity Assay Labeling Correction: Reduced On-Board Stability
FDA (Devices) · 2021-10-27
- ModerateBF-P180 EVIS EXERA II Bronchovideoscope Reprocessing Instructions Validation Recall
FDA (Devices) · 2021-10-06